Contrary to the long-recognized negative immune regulation of ATP-adenosine signal in tumor tissue and the increase of CD73 associated with poor prognosis, the researchers found that the expression of CD73 on CD8+ T cells in patients with AML is related to the enhancement of immune response and has a higher function (67). This evidence concerns the gene CD8A and acute myeloid leukemia.